Global Adult Vaccines Market & Company Analysis 2015-2020 Featuring GSK, Sanofi Pasteur, Merck, Novartis and Pfizer
DUBLIN, May 14, 2015 /PRNewswire/ --Research and Markets
(http://www.researchandmarkets.com/research/c3vxfw/global_adult) has announced the addition of the "Global - Adult Vaccines Market & Company Analysis to 2020" report to their offering
The influenza vaccines are the most popular and accepted vaccination amongst adults. It accounted for maximum share of adult vaccines market in 2014. The vaccinations for hepatitis is the second most popular vaccines in 2014. The HPV/Cervical cancer vaccines and pneumococcal vaccines stands at third and fourth spots respectively in adult vaccines market. While vaccines for zoster shingles and DTP are also gaining ground in adult vaccines market landscape.
Adult Vaccines Market - Company Analysis:
Note: Novartis divested its non-influenza vaccine business to GlaxoSmithKline (GSK) and CSL acquires Novartis influenza vaccines business.
In 2010, GSK was the leader in the adult vaccines market but it lost the leadership position to Merck. Sanofi Pasteur stands at the second spot in the adult vaccines market. GSK slipped to third position in the global adult vaccines market in 2014. While Pfizer and Novartis is at the fourth and fifth position respectively in the adult vaccines market landscape.
Adult Vaccines Market - Disease Wise Company Sales Analysis:
GSK generates maximum adult vaccines sales from Hepatitis and DTP vaccines, while Sanofi Pasteur remains focused on maintaining its leadership in the influenza market. The cervical cancer and zoster shingles vaccines contributes maximum share of the total Merck adult vaccines sales. Novartis main source of adult vaccines sales revenue is the influenza vaccines.
Adult Vaccines Market - Regional Distribution:
On a regional basis the United States comprises the single largest market for adult vaccines being closely followed by Europe. Japan's adult vaccines market share is expected to remain flat during the forecasting period. South America and India are competing closely with each other to get the maximum share of the adult vaccines market pie.
This report is a 232 page report with 142 Figures and 8 Tables. This report studies in detail the adult vaccines market disease wise, company wise sales analysis and strategic alliances, mergers and acquisitions along with growth drivers and hindrances for the vaccines market landscape.
The 9 Diseases covered in the report are analyzed from four viewpoints:
1. Adult Vaccines Market (2007 - 2020)
2. Number of Adults Vaccinated (2007 - 2020)
3. Number of Doses (2007 - 2020)
4. Company Sales Share (2010 - 2020)
The 6 Company covered in the report are analyzed from two viewpoints:
1. Disease Wise - Adult Vaccines Sales (2007 - 2020)
2. Strategic Alliances
The 8 Region covered in the report are analyzed from one viewpoint:
1. Adult Vaccines Market (2011 - 2020)
Global Adult Vaccines Market, Number of Adults Vaccinated and Doses - Disease Wise Analysis to 2020 (9 Disease Analysed)
1. Influenza
2. Cervical Cancer
3. Zoster Shingles
4. Pneumococcal
5. Meningococcal
6. MMRV
7. Hepatitis
8. DTP
9. Travel and Miscellaneous
Global Adult Vaccines Market - Company Analysis to 2020 (6 Company Analysed)
1. GlaxoSmithKline
2. Sanofi Pasteur
3. Merck
4. Novartis
5. Pfizer
6. Other Companies
Global Adult Vaccines Market - Regional Distribution to 2020 (8 Region Analysed)
1. United States
2. North America/Caribbean
3. South America
4. Europe
5. Japan
6. India
7. China
8. Rest of the World
For more information visit http://www.researchandmarkets.com/research/c3vxfw/global_adult
Media Contact: Lauraa Wood , +353-1-481-1716, press@researchandmarkets.net
Share this article